Buy Momenta Pharmaceuticals Stock | MNTA Stock Price & Latest News | Public
MNTA

Momenta Pharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About MNTA

    Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium in...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.17
    -0.34
    -0.52
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.52

    Actual EPS
    Q4 2020

    Stats

    Market Cap$6,24B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$52.53
    1 Year Low$12.58
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app